PubMed · PMID 20797828
CD4+ CD25(high) regulatory T cell in childhood ocular myasthenia gravis.
PMID 20797828Journal Brain & developmentYear 2011Authors 7DOI 10.1016/j.braindev.2010.08.002
Abstract
Dysfunction of CD4(+)CD25(+) regulatory T cell (Treg) has been demonstrated to play an important role in the development of autoimmune myasthenia gravis. This T cell subset, which has potent regulatory properties against immune response, has been reported to have a numerical or functional defect in patients with myasthenia gravis. We examined various T cell subsets, including CD4(+)CD25(+)Treg in peripheral blood mononuclear cells using flow cytometry in a pediatric patient suffering from ocular myasthenia gravis. Contrary to previous reports, the percentage of CD4(+)CD25(+)Treg in peripheral blood decreased significantly after successful treatment with prednisolone.
This discrepancy could result from diversity within the immunopathogenesis of myasthenia gravis and may underpin a particular subgroup of myasthenia gravis seen in the East-Asian pediatric population.
Record details
| PMID | 20797828 |
|---|---|
| PMCID | not held |
| DOI | 10.1016/j.braindev.2010.08.002 |
| Journal | Brain & development |
| Year | 2011 |
| Authors | Hiroshi Sakuma; Ayako Katayama; Yoshiaki Saito; Hirofumi Komaki; Eiji Nakagawa; Kenji Sugai; Masayuki Sasaki |
| Licence | not stated |
| MeSH | CD4 Antigens; Child, Preschool; Female; Humans; Interleukin-2 Receptor alpha Subunit; Lymphocyte Subsets; Myasthenia Gravis; T-Lymphocytes, Regulatory |
Source record
Open the PubMed record. This page holds the abstract and citation fields for this PMID; no PMC full text is held for it.